跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,702 条关于
“homologous recombination deficiencies”
全部
15,702
临床试验
14,429
药物
98
机构
2
资讯
1,173
去年
Duke Street Bio Receives EMA Approval for First-in-Human Trial of PARP1 Inhibitor DSB2455
4年前
PARP Inhibitors Show Promise in Ovarian Cancer Maintenance Therapy
去年
Veliparib Shows Promise in BRCA-Mutated Breast Cancer: Phase II Trial Results
6年前
PARP Inhibitors in Frontline Ovarian Cancer Treatment: A Review of Clinical Trials
2年前
Pidnarulex Shows Promise in Advanced Solid Tumors with BRCA/PALB2 Mutations
去年
Saruparib Shows Promise as Selective PARP1 Inhibitor in Advanced Solid Tumors
去年
QIAGEN Unveils Advanced Cancer Genomic Profiling Tools at AACR 2025
去年
Eisbach Bio Relocates to Houston with $4.75M CPRIT Grant to Advance EIS-12656 Trial in HRD Tumors
去年
Niraparib Maintenance Shows Sustained Progression-Free Survival Benefit in Advanced Ovarian Cancer, But No Overall Survival Improvement
2个月前
PARP Inhibitors Expand Beyond BRCA-Mutated Cancers: Emerging Evidence Across Solid Tumors and Combination Strategies
第 1 页，共 118 页
上一页
下一页
